BGM Group Ltd. (BGM) 10-Year Financial Performance & Capital Metrics

BGM • • Industrial / General

HealthcareSpecialty & Generic PharmaContract Manufacturing & APIAPI Manufacturers

AboutBGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was formerly known as Qilian International Holding Group Limited and changed its name to BGM Group Ltd in October 2024. BGM Group Ltd was incorporated in 2019 and is based in Chengdu, the People's Republic of China.Show more

Revenue $25M -46.0%
EBITDA $673K +145.9%
Net Income -$1M +81.5%
EPS (Diluted) -0.20 +81.5%
Gross Margin 16.39% +335.0%
EBITDA Margin 2.68% +185.0%
Operating Margin -2.25% +60.0%
Net Margin -5.75% +65.7%
ROE -3.26% +79.2%
ROIC -1.18% +75.9%
Debt/Equity -
Interest Coverage -0.88

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 0.6x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 3 (bottom 3%)
✗Sales declining 11.4% over 5 years
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-11.45%

3Y-23.97%

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-

EPS CAGR

10Y-

5Y-

3Y-

TTM-

ROCE

10Y Avg11.47%

5Y Avg4.16%

3Y Avg-0.92%

Latest-1.27%

Peer Comparison

API Manufacturers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
TKNOAlpha Teknova, Inc.	220.54M	4.12	-7.23	2.89%	-45.78%	-25.08%		0.37
BGMBGM Group Ltd.	659.28M	3.65	-18.25	-45.99%	-5.75%	-3.26%

Profit & Loss

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Sales/Revenue+	22.54M	50.37M	46.1M	50.03M	57.1M	64.86M	46.47M	25.1M
Revenue Growth %	-	1.23%	-0.08%	0.09%	0.14%	0.14%	-0.28%	-0.46%
Cost of Goods Sold+	19.16M	42.24M	36.42M	42.49M	51.46M	58.63M	44.72M	20.98M
COGS % of Revenue	0.85%	0.84%	0.79%	0.85%	0.9%	0.9%	0.96%	0.84%
Gross Profit+	3.38M	8.13M	9.68M	7.54M	5.64M	6.23M	1.75M	4.11M
Gross Margin %	0.15%	0.16%	0.21%	0.15%	0.1%	0.1%	0.04%	0.16%
Gross Profit Growth %	-	1.4%	0.19%	-0.22%	-0.25%	0.1%	-0.72%	1.35%
Operating Expenses+	2.25M	2.16M	3.5M	2.73M	3.25M	4.13M	4.36M	4.68M
OpEx % of Revenue	0.1%	0.04%	0.08%	0.05%	0.06%	0.06%	0.09%	0.19%
Selling, General & Admin	2.25M	2.16M	3.5M	2.73M	3.25M	2.9M	3.79M	3.32M
SG&A % of Revenue	0.1%	0.04%	0.08%	0.05%	0.06%	0.04%	0.08%	0.13%
Research & Development	0	0	0	0	0	1.22M	568.47K	1.36M
R&D % of Revenue	-	-	-	-	-	0.02%	0.01%	0.05%
Other Operating Expenses	0	0	0	0	0	0	0	0
Operating Income+	1.13M	5.97M	6.18M	4.81M	2.39M	2.1M	-2.61M	-563.77K
Operating Margin %	0.05%	0.12%	0.13%	0.1%	0.04%	0.03%	-0.06%	-0.02%
Operating Income Growth %	-	4.28%	0.03%	-0.22%	-0.5%	-0.12%	-2.24%	0.78%
EBITDA+	2.37M	7.23M	7.37M	5.98M	3.59M	3.33M	-1.47M	673.46K
EBITDA Margin %	0.11%	0.14%	0.16%	0.12%	0.06%	0.05%	-0.03%	0.03%
EBITDA Growth %	-	2.05%	0.02%	-0.19%	-0.4%	-0.07%	-1.44%	1.46%
D&A (Non-Cash Add-back)	1.24M	1.25M	1.19M	1.17M	1.2M	1.22M	1.14M	1.24M
EBIT	2.14M	6.36M	7.17M	6.05M	2.95M	2.52M	-2.42M	-357.36K
Net Interest Income+	-282.84K	-216.19K	-223.66K	-242.88K	-57.67K	24.86K	99.19K	-639.51K
Interest Income	0	0	0	0	0	24.86K	99.19K	0
Interest Expense	282.84K	216.19K	223.66K	242.88K	57.67K	0	0	639.51K
Other Income/Expense	728.92K	174.6K	763.38K	994.21K	975.23K	-541.44K	-5.29M	-1.57M
Pretax Income+	1.86M	6.15M	6.94M	5.81M	3.36M	1.56M	-7.9M	-2.14M
Pretax Margin %	0.08%	0.12%	0.15%	0.12%	0.06%	0.02%	-0.17%	-0.09%
Income Tax+	321.46K	943.36K	1.03M	864.91K	255.13K	194.3K	219.17K	-619.98K
Effective Tax Rate %	0.76%	0.84%	0.77%	0.87%	0.94%	0.69%	0.98%	0.68%
Net Income+	1.41M	5.17M	5.33M	5.06M	3.15M	1.08M	-7.78M	-1.44M
Net Margin %	0.06%	0.1%	0.12%	0.1%	0.06%	0.02%	-0.17%	-0.06%
Net Income Growth %	-	2.65%	0.03%	-0.05%	-0.38%	-0.66%	-8.23%	0.81%
Net Income (Continuing)	1.54M	5.2M	5.91M	4.94M	3.11M	1.37M	-8.12M	-1.52M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	2.41M	2.4M	2.74M	2.74M	1.81M	1.91M	1.56M	1.35M
EPS (Diluted)+	0.20	0.74	0.76	0.72	0.45	0.15	-1.08	-0.20
EPS Growth %	-	2.7%	0.03%	-0.05%	-0.38%	-0.67%	-8.2%	0.81%
EPS (Basic)	0.20	0.74	0.76	0.72	0.45	0.15	-1.08	-0.20
Diluted Shares Outstanding	7M	7M	7M	7M	6.82M	7.23M	7.23M	7.23M
Basic Shares Outstanding	7M	7M	7M	7M	6.82M	7.23M	7.23M	7.23M
Dividend Payout Ratio	-	0.14%	-	-	-	-	-	-

Balance Sheet

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Total Current Assets+	21.96M	22.17M	24.97M	37.52M	40.37M	30.03M	34.51M	29.77M
Cash & Short-Term Investments	5.37M	5.28M	4.59M	11.87M	10.47M	14.32M	22.42M	18.14M
Cash Only	5.37M	5.26M	4.59M	11.87M	10.47M	14.32M	7.48M	9.82M
Short-Term Investments	0	14.58K	0	0	0	0	14.94M	8.32M
Accounts Receivable	1.01M	5.29M	6.14M	12.62M	13.47M	4.87M	6.35M	5.77M
Days Sales Outstanding	16.33	38.36	48.62	92.1	86.1	27.42	49.91	83.98
Inventory	12.85M	9.59M	12.52M	11.99M	12.5M	8.88M	4.99M	5.05M
Days Inventory Outstanding	244.95	82.84	125.52	103.03	88.63	55.28	40.74	87.84
Other Current Assets	944K	363.99K	351.92K	384.85K	2.14M	659.78K	0	0
Total Non-Current Assets+	11.43M	11.17M	10.3M	10.63M	34.99M	34.49M	16.75M	23.23M
Property, Plant & Equipment	8.84M	8.49M	7.67M	7.66M	11.48M	12.29M	12.71M	14.91M
Fixed Asset Turnover	2.55x	5.93x	6.01x	6.53x	4.97x	5.28x	3.66x	1.68x
Goodwill	0	0	0	0	0	0	0	0
Intangible Assets	2.07M	1.96M	1.83M	1.88M	1.93M	1.73M	3.42M	4.54M
Long-Term Investments	163.03K	407.35K	539.68K	540.52K	20.96M	20.09M	606K	3.36M
Other Non-Current Assets	0	0	0	179.32K	188.91K	172.91K	0	0
Total Assets+	33.38M	33.34M	35.27M	48.14M	75.35M	64.53M	51.26M	53M
Asset Turnover	0.68x	1.51x	1.31x	1.04x	0.76x	1.01x	0.91x	0.47x
Asset Growth %	-	-0%	0.06%	0.37%	0.57%	-0.14%	-0.21%	0.03%
Total Current Liabilities+	17.97M	14.29M	11.66M	18.42M	18.17M	9.18M	6.66M	8.78M
Accounts Payable	4.69M	3.76M	3.57M	4.38M	6.64M	5.29M	3.59M	4.13M
Days Payables Outstanding	89.29	32.47	35.78	37.6	47.12	32.93	29.32	71.76
Short-Term Debt	6.94M	4.22M	4.9M	7.35M	7.87M	1.67M	479.71K	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	677.96K	1000K	568.5K
Other Current Liabilities	0	0	0	0	0	0	0	0
Current Ratio	1.22x	1.55x	2.14x	2.04x	2.22x	3.27x	5.18x	3.39x
Quick Ratio	0.51x	0.88x	1.07x	1.39x	1.53x	2.30x	4.43x	2.82x
Cash Conversion Cycle	171.99	88.73	138.35	157.52	127.61	49.77	61.33	100.06
Total Non-Current Liabilities+	1.76M	1.33M	972.34K	877.86K	509.93K	382.48K	246.45K	134.39K
Long-Term Debt	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	155.72K	106.18K	72.54K	24.57K	0
Deferred Tax Liabilities	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0
Total Liabilities	19.73M	15.62M	12.63M	19.3M	18.68M	9.56M	6.91M	8.91M
Total Debt+	6.94M	4.22M	4.9M	7.59M	8.03M	1.77M	577.85K	0
Net Debt	1.58M	-1.04M	308.69K	-4.28M	-2.44M	-12.55M	-6.9M	-9.82M
Debt / Equity	0.51x	0.24x	0.22x	0.26x	0.14x	0.03x	0.01x	-
Debt / EBITDA	2.93x	0.58x	0.67x	1.27x	2.24x	0.53x	-	-
Net Debt / EBITDA	0.66x	-0.14x	0.04x	-0.72x	-0.68x	-3.77x	-	-14.58x
Interest Coverage	4.00x	27.62x	27.63x	19.81x	41.41x	-	-	-0.88x
Total Equity+	13.66M	17.72M	22.64M	28.84M	56.67M	54.96M	44.35M	44.09M
Equity Growth %	-	0.3%	0.28%	0.27%	0.96%	-0.03%	-0.19%	-0.01%
Book Value per Share	1.95	2.53	3.23	4.12	8.31	7.61	6.14	6.10
Total Shareholders' Equity	11.24M	15.32M	19.89M	26.1M	54.86M	53.05M	42.79M	42.74M
Common Stock	50K	50K	50K	50K	59.58K	59.58K	59.58K	59.58K
Retained Earnings	3.06M	2.87M	7.56M	12.2M	14.69M	15.51M	5.9M	4.35M
Treasury Stock	0	0	0	0	0	0	0	0
Accumulated OCI	440.33K	150.36K	30.64K	1.6M	3.71M	1.07M	425.25K	1.92M
Minority Interest	2.41M	2.4M	2.74M	2.74M	1.81M	1.91M	1.56M	1.35M

Cash Flow

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Cash from Operations+	2.68M	4.44M	-580.2K	5.08M	345.03K	12.65M	312.21K	544.24K
Operating CF Margin %	0.12%	0.09%	-0.01%	0.1%	0.01%	0.2%	0.01%	0.02%
Operating CF Growth %	-	0.65%	-1.13%	9.75%	-0.93%	35.68%	-0.98%	0.74%
Net Income	1.54M	5.2M	5.91M	4.94M	3.11M	1.37M	-8.12M	-1.52M
Depreciation & Amortization	1.24M	1.25M	1.19M	1.17M	1.2M	1.22M	1.14M	1.24M
Stock-Based Compensation	0	0	0	0	0	20K	0	0
Deferred Taxes	57.51K	15.8K	48.66K	-86.5K	-46.19K	189.84K	203.54K	-406.85K
Other Non-Cash Items	71.87K	205.47K	-30.78K	-160.86K	-246.34K	1.1M	5.98M	445.31K
Working Capital Changes	-227.6K	-2.24M	-7.69M	-785.07K	-3.67M	8.75M	1.11M	785.7K
Change in Receivables	1.86M	-4.06M	-1.46M	-6.24M	-157.5K	9.77M	-2.89M	1.33M
Change in Inventory	-7.26M	2.81M	-3.49M	1.4M	46.8K	2.23M	3.4M	958.65K
Change in Payables	2.72M	-824.54K	-50.04K	613.34K	2.02M	-805.44K	-1.62M	378.98K
Cash from Investing+	-1.69M	-1.39M	-800.18K	-375.59K	-24.2M	-3.26M	-4.74M	983.42K
Capital Expenditures	-1.52M	-1.12M	-616.39K	-449.77K	-3.49M	-3.23M	-1.85M	-2.85M
CapEx % of Revenue	0.07%	0.02%	0.01%	0.01%	0.06%	0.05%	0.04%	0.11%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	-7.13K	0	-635	-8.8K	-1.81K	-26.68K	-1.87M	-1.02M
Cash from Financing+	1.25M	-3.12M	507.2K	2.14M	23.99M	-5.94M	-2.92M	-491.73K
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	0	-733.94K	0	0	0	0	-1.79M	0
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	-493.14K	247.7K	-365.31K	0	0	0	56.71K	0
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	1.15M	3.32M	-1.2M	0	-3.15M	9.4M	-3.4M	-3.39M
FCF Margin %	0.05%	0.07%	-0.03%	-	-0.06%	0.14%	-0.07%	-0.13%
FCF Growth %	-	1.88%	-1.36%	1%	-	3.98%	-1.36%	0%
FCF per Share	0.16	0.47	-0.17	-	-0.46	1.30	-0.47	-0.47
FCF Conversion (FCF/Net Income)	1.90x	0.86x	-0.11x	1.00x	0.11x	11.75x	-0.04x	-0.38x
Interest Paid	281.7K	223.77K	210.59K	280.17K	152.5K	122.24K	3.66K	4.26K
Taxes Paid	48K	658.41K	1.11M	275.61K	820.97K	0	27.44K	21.91K

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	10.36%	32.95%	26.42%	19.67%	7.37%	1.93%	-15.67%	-3.26%
Return on Invested Capital (ROIC)	5.57%	28.06%	23.39%	15.19%	4.55%	3.26%	-4.9%	-1.18%
Gross Margin	15.01%	16.15%	21%	15.07%	9.87%	9.6%	3.77%	16.39%
Net Margin	6.28%	10.26%	11.57%	10.12%	5.52%	1.66%	-16.74%	-5.75%
Debt / Equity	0.51x	0.24x	0.22x	0.26x	0.14x	0.03x	0.01x	-
Interest Coverage	4.00x	27.62x	27.63x	19.81x	41.41x	-	-	-0.88x
FCF Conversion	1.90x	0.86x	-0.11x	1.00x	0.11x	11.75x	-0.04x	-0.38x
Revenue Growth	-	123.49%	-8.48%	8.54%	14.12%	13.58%	-28.35%	-45.99%

Frequently Asked Questions

Growth & Financials

BGM Group Ltd. (BGM) reported $25.1M in revenue for fiscal year 2024. This represents a 11% increase from $22.5M in 2017.

BGM Group Ltd. (BGM) saw revenue decline by 46.0% over the past year.

BGM Group Ltd. (BGM) reported a net loss of $1.4M for fiscal year 2024.

Dividend & Returns

BGM Group Ltd. (BGM) has a return on equity (ROE) of -3.3%. Negative ROE indicates the company is unprofitable.

BGM Group Ltd. (BGM) had negative free cash flow of $3.4M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

BGM Group Ltd. (BGM) 10-Year Financial Performance & Capital Metrics

BGM • • Industrial / General

HealthcareSpecialty & Generic PharmaContract Manufacturing & APIAPI Manufacturers

Revenue $25M -46.0%
EBITDA $673K +145.9%
Net Income -$1M +81.5%
EPS (Diluted) -0.20 +81.5%
Gross Margin 16.39% +335.0%
EBITDA Margin 2.68% +185.0%
Operating Margin -2.25% +60.0%
Net Margin -5.75% +65.7%
ROE -3.26% +79.2%
ROIC -1.18% +75.9%
Debt/Equity -
Interest Coverage -0.88

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 0.6x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 3 (bottom 3%)
✗Sales declining 11.4% over 5 years
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-11.45%

3Y-23.97%

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-

EPS CAGR

10Y-

5Y-

3Y-

TTM-

ROCE

10Y Avg11.47%

5Y Avg4.16%

3Y Avg-0.92%

Latest-1.27%

Peer Comparison

API Manufacturers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
TKNOAlpha Teknova, Inc.	220.54M	4.12	-7.23	2.89%	-45.78%	-25.08%		0.37
BGMBGM Group Ltd.	659.28M	3.65	-18.25	-45.99%	-5.75%	-3.26%

Profit & Loss

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Sales/Revenue+	22.54M	50.37M	46.1M	50.03M	57.1M	64.86M	46.47M	25.1M
Revenue Growth %	-	1.23%	-0.08%	0.09%	0.14%	0.14%	-0.28%	-0.46%
Cost of Goods Sold+	19.16M	42.24M	36.42M	42.49M	51.46M	58.63M	44.72M	20.98M
COGS % of Revenue	0.85%	0.84%	0.79%	0.85%	0.9%	0.9%	0.96%	0.84%
Gross Profit+	3.38M	8.13M	9.68M	7.54M	5.64M	6.23M	1.75M	4.11M
Gross Margin %	0.15%	0.16%	0.21%	0.15%	0.1%	0.1%	0.04%	0.16%
Gross Profit Growth %	-	1.4%	0.19%	-0.22%	-0.25%	0.1%	-0.72%	1.35%
Operating Expenses+	2.25M	2.16M	3.5M	2.73M	3.25M	4.13M	4.36M	4.68M
OpEx % of Revenue	0.1%	0.04%	0.08%	0.05%	0.06%	0.06%	0.09%	0.19%
Selling, General & Admin	2.25M	2.16M	3.5M	2.73M	3.25M	2.9M	3.79M	3.32M
SG&A % of Revenue	0.1%	0.04%	0.08%	0.05%	0.06%	0.04%	0.08%	0.13%
Research & Development	0	0	0	0	0	1.22M	568.47K	1.36M
R&D % of Revenue	-	-	-	-	-	0.02%	0.01%	0.05%
Other Operating Expenses	0	0	0	0	0	0	0	0
Operating Income+	1.13M	5.97M	6.18M	4.81M	2.39M	2.1M	-2.61M	-563.77K
Operating Margin %	0.05%	0.12%	0.13%	0.1%	0.04%	0.03%	-0.06%	-0.02%
Operating Income Growth %	-	4.28%	0.03%	-0.22%	-0.5%	-0.12%	-2.24%	0.78%
EBITDA+	2.37M	7.23M	7.37M	5.98M	3.59M	3.33M	-1.47M	673.46K
EBITDA Margin %	0.11%	0.14%	0.16%	0.12%	0.06%	0.05%	-0.03%	0.03%
EBITDA Growth %	-	2.05%	0.02%	-0.19%	-0.4%	-0.07%	-1.44%	1.46%
D&A (Non-Cash Add-back)	1.24M	1.25M	1.19M	1.17M	1.2M	1.22M	1.14M	1.24M
EBIT	2.14M	6.36M	7.17M	6.05M	2.95M	2.52M	-2.42M	-357.36K
Net Interest Income+	-282.84K	-216.19K	-223.66K	-242.88K	-57.67K	24.86K	99.19K	-639.51K
Interest Income	0	0	0	0	0	24.86K	99.19K	0
Interest Expense	282.84K	216.19K	223.66K	242.88K	57.67K	0	0	639.51K
Other Income/Expense	728.92K	174.6K	763.38K	994.21K	975.23K	-541.44K	-5.29M	-1.57M
Pretax Income+	1.86M	6.15M	6.94M	5.81M	3.36M	1.56M	-7.9M	-2.14M
Pretax Margin %	0.08%	0.12%	0.15%	0.12%	0.06%	0.02%	-0.17%	-0.09%
Income Tax+	321.46K	943.36K	1.03M	864.91K	255.13K	194.3K	219.17K	-619.98K
Effective Tax Rate %	0.76%	0.84%	0.77%	0.87%	0.94%	0.69%	0.98%	0.68%
Net Income+	1.41M	5.17M	5.33M	5.06M	3.15M	1.08M	-7.78M	-1.44M
Net Margin %	0.06%	0.1%	0.12%	0.1%	0.06%	0.02%	-0.17%	-0.06%
Net Income Growth %	-	2.65%	0.03%	-0.05%	-0.38%	-0.66%	-8.23%	0.81%
Net Income (Continuing)	1.54M	5.2M	5.91M	4.94M	3.11M	1.37M	-8.12M	-1.52M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	2.41M	2.4M	2.74M	2.74M	1.81M	1.91M	1.56M	1.35M
EPS (Diluted)+	0.20	0.74	0.76	0.72	0.45	0.15	-1.08	-0.20
EPS Growth %	-	2.7%	0.03%	-0.05%	-0.38%	-0.67%	-8.2%	0.81%
EPS (Basic)	0.20	0.74	0.76	0.72	0.45	0.15	-1.08	-0.20
Diluted Shares Outstanding	7M	7M	7M	7M	6.82M	7.23M	7.23M	7.23M
Basic Shares Outstanding	7M	7M	7M	7M	6.82M	7.23M	7.23M	7.23M
Dividend Payout Ratio	-	0.14%	-	-	-	-	-	-

Balance Sheet

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Total Current Assets+	21.96M	22.17M	24.97M	37.52M	40.37M	30.03M	34.51M	29.77M
Cash & Short-Term Investments	5.37M	5.28M	4.59M	11.87M	10.47M	14.32M	22.42M	18.14M
Cash Only	5.37M	5.26M	4.59M	11.87M	10.47M	14.32M	7.48M	9.82M
Short-Term Investments	0	14.58K	0	0	0	0	14.94M	8.32M
Accounts Receivable	1.01M	5.29M	6.14M	12.62M	13.47M	4.87M	6.35M	5.77M
Days Sales Outstanding	16.33	38.36	48.62	92.1	86.1	27.42	49.91	83.98
Inventory	12.85M	9.59M	12.52M	11.99M	12.5M	8.88M	4.99M	5.05M
Days Inventory Outstanding	244.95	82.84	125.52	103.03	88.63	55.28	40.74	87.84
Other Current Assets	944K	363.99K	351.92K	384.85K	2.14M	659.78K	0	0
Total Non-Current Assets+	11.43M	11.17M	10.3M	10.63M	34.99M	34.49M	16.75M	23.23M
Property, Plant & Equipment	8.84M	8.49M	7.67M	7.66M	11.48M	12.29M	12.71M	14.91M
Fixed Asset Turnover	2.55x	5.93x	6.01x	6.53x	4.97x	5.28x	3.66x	1.68x
Goodwill	0	0	0	0	0	0	0	0
Intangible Assets	2.07M	1.96M	1.83M	1.88M	1.93M	1.73M	3.42M	4.54M
Long-Term Investments	163.03K	407.35K	539.68K	540.52K	20.96M	20.09M	606K	3.36M
Other Non-Current Assets	0	0	0	179.32K	188.91K	172.91K	0	0
Total Assets+	33.38M	33.34M	35.27M	48.14M	75.35M	64.53M	51.26M	53M
Asset Turnover	0.68x	1.51x	1.31x	1.04x	0.76x	1.01x	0.91x	0.47x
Asset Growth %	-	-0%	0.06%	0.37%	0.57%	-0.14%	-0.21%	0.03%
Total Current Liabilities+	17.97M	14.29M	11.66M	18.42M	18.17M	9.18M	6.66M	8.78M
Accounts Payable	4.69M	3.76M	3.57M	4.38M	6.64M	5.29M	3.59M	4.13M
Days Payables Outstanding	89.29	32.47	35.78	37.6	47.12	32.93	29.32	71.76
Short-Term Debt	6.94M	4.22M	4.9M	7.35M	7.87M	1.67M	479.71K	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	677.96K	1000K	568.5K
Other Current Liabilities	0	0	0	0	0	0	0	0
Current Ratio	1.22x	1.55x	2.14x	2.04x	2.22x	3.27x	5.18x	3.39x
Quick Ratio	0.51x	0.88x	1.07x	1.39x	1.53x	2.30x	4.43x	2.82x
Cash Conversion Cycle	171.99	88.73	138.35	157.52	127.61	49.77	61.33	100.06
Total Non-Current Liabilities+	1.76M	1.33M	972.34K	877.86K	509.93K	382.48K	246.45K	134.39K
Long-Term Debt	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	155.72K	106.18K	72.54K	24.57K	0
Deferred Tax Liabilities	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0
Total Liabilities	19.73M	15.62M	12.63M	19.3M	18.68M	9.56M	6.91M	8.91M
Total Debt+	6.94M	4.22M	4.9M	7.59M	8.03M	1.77M	577.85K	0
Net Debt	1.58M	-1.04M	308.69K	-4.28M	-2.44M	-12.55M	-6.9M	-9.82M
Debt / Equity	0.51x	0.24x	0.22x	0.26x	0.14x	0.03x	0.01x	-
Debt / EBITDA	2.93x	0.58x	0.67x	1.27x	2.24x	0.53x	-	-
Net Debt / EBITDA	0.66x	-0.14x	0.04x	-0.72x	-0.68x	-3.77x	-	-14.58x
Interest Coverage	4.00x	27.62x	27.63x	19.81x	41.41x	-	-	-0.88x
Total Equity+	13.66M	17.72M	22.64M	28.84M	56.67M	54.96M	44.35M	44.09M
Equity Growth %	-	0.3%	0.28%	0.27%	0.96%	-0.03%	-0.19%	-0.01%
Book Value per Share	1.95	2.53	3.23	4.12	8.31	7.61	6.14	6.10
Total Shareholders' Equity	11.24M	15.32M	19.89M	26.1M	54.86M	53.05M	42.79M	42.74M
Common Stock	50K	50K	50K	50K	59.58K	59.58K	59.58K	59.58K
Retained Earnings	3.06M	2.87M	7.56M	12.2M	14.69M	15.51M	5.9M	4.35M
Treasury Stock	0	0	0	0	0	0	0	0
Accumulated OCI	440.33K	150.36K	30.64K	1.6M	3.71M	1.07M	425.25K	1.92M
Minority Interest	2.41M	2.4M	2.74M	2.74M	1.81M	1.91M	1.56M	1.35M

Cash Flow

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Cash from Operations+	2.68M	4.44M	-580.2K	5.08M	345.03K	12.65M	312.21K	544.24K
Operating CF Margin %	0.12%	0.09%	-0.01%	0.1%	0.01%	0.2%	0.01%	0.02%
Operating CF Growth %	-	0.65%	-1.13%	9.75%	-0.93%	35.68%	-0.98%	0.74%
Net Income	1.54M	5.2M	5.91M	4.94M	3.11M	1.37M	-8.12M	-1.52M
Depreciation & Amortization	1.24M	1.25M	1.19M	1.17M	1.2M	1.22M	1.14M	1.24M
Stock-Based Compensation	0	0	0	0	0	20K	0	0
Deferred Taxes	57.51K	15.8K	48.66K	-86.5K	-46.19K	189.84K	203.54K	-406.85K
Other Non-Cash Items	71.87K	205.47K	-30.78K	-160.86K	-246.34K	1.1M	5.98M	445.31K
Working Capital Changes	-227.6K	-2.24M	-7.69M	-785.07K	-3.67M	8.75M	1.11M	785.7K
Change in Receivables	1.86M	-4.06M	-1.46M	-6.24M	-157.5K	9.77M	-2.89M	1.33M
Change in Inventory	-7.26M	2.81M	-3.49M	1.4M	46.8K	2.23M	3.4M	958.65K
Change in Payables	2.72M	-824.54K	-50.04K	613.34K	2.02M	-805.44K	-1.62M	378.98K
Cash from Investing+	-1.69M	-1.39M	-800.18K	-375.59K	-24.2M	-3.26M	-4.74M	983.42K
Capital Expenditures	-1.52M	-1.12M	-616.39K	-449.77K	-3.49M	-3.23M	-1.85M	-2.85M
CapEx % of Revenue	0.07%	0.02%	0.01%	0.01%	0.06%	0.05%	0.04%	0.11%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	-7.13K	0	-635	-8.8K	-1.81K	-26.68K	-1.87M	-1.02M
Cash from Financing+	1.25M	-3.12M	507.2K	2.14M	23.99M	-5.94M	-2.92M	-491.73K
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	0	-733.94K	0	0	0	0	-1.79M	0
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	-493.14K	247.7K	-365.31K	0	0	0	56.71K	0
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	1.15M	3.32M	-1.2M	0	-3.15M	9.4M	-3.4M	-3.39M
FCF Margin %	0.05%	0.07%	-0.03%	-	-0.06%	0.14%	-0.07%	-0.13%
FCF Growth %	-	1.88%	-1.36%	1%	-	3.98%	-1.36%	0%
FCF per Share	0.16	0.47	-0.17	-	-0.46	1.30	-0.47	-0.47
FCF Conversion (FCF/Net Income)	1.90x	0.86x	-0.11x	1.00x	0.11x	11.75x	-0.04x	-0.38x
Interest Paid	281.7K	223.77K	210.59K	280.17K	152.5K	122.24K	3.66K	4.26K
Taxes Paid	48K	658.41K	1.11M	275.61K	820.97K	0	27.44K	21.91K

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	10.36%	32.95%	26.42%	19.67%	7.37%	1.93%	-15.67%	-3.26%
Return on Invested Capital (ROIC)	5.57%	28.06%	23.39%	15.19%	4.55%	3.26%	-4.9%	-1.18%
Gross Margin	15.01%	16.15%	21%	15.07%	9.87%	9.6%	3.77%	16.39%
Net Margin	6.28%	10.26%	11.57%	10.12%	5.52%	1.66%	-16.74%	-5.75%
Debt / Equity	0.51x	0.24x	0.22x	0.26x	0.14x	0.03x	0.01x	-
Interest Coverage	4.00x	27.62x	27.63x	19.81x	41.41x	-	-	-0.88x
FCF Conversion	1.90x	0.86x	-0.11x	1.00x	0.11x	11.75x	-0.04x	-0.38x
Revenue Growth	-	123.49%	-8.48%	8.54%	14.12%	13.58%	-28.35%	-45.99%

Frequently Asked Questions

Growth & Financials

BGM Group Ltd. (BGM) reported $25.1M in revenue for fiscal year 2024. This represents a 11% increase from $22.5M in 2017.

BGM Group Ltd. (BGM) saw revenue decline by 46.0% over the past year.

BGM Group Ltd. (BGM) reported a net loss of $1.4M for fiscal year 2024.

Dividend & Returns

BGM Group Ltd. (BGM) has a return on equity (ROE) of -3.3%. Negative ROE indicates the company is unprofitable.

BGM Group Ltd. (BGM) had negative free cash flow of $3.4M in fiscal year 2024, likely due to heavy capital investments.